Turnstone Biologics Corp. Operating Income
Turnstone Biologics Corp. reported Operating Income of -$5.56 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-08-08
- Turnstone Biologics Corp. operating income (loss) for the quarter ending 2025-06-30 was -$5.56M.
- Turnstone Biologics Corp. operating income (loss) for the quarter ending 2025-03-31 was -$9.16M.
- Turnstone Biologics Corp. operating income (loss) for the quarter ending 2024-12-31 was -$11.38M.
- Turnstone Biologics Corp. operating income (loss) for the quarter ending 2024-09-30 was -$18.37M.
- Turnstone Biologics Corp. operating income (loss) for fiscal 2024 was -$72.49M.
- Turnstone Biologics Corp. operating income (loss) for fiscal 2023 was -$59.03M.
- Turnstone Biologics Corp. operating income (loss) for fiscal 2022 was -$31.63M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$5.56M 10-Q · filed 2025-08-08 | -$14.72M 10-Q · filed 2025-08-08 | -$26.10M derived: sum of 3 quarters · filed 2025-08-08 | -$44.47M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | -$9.16M 10-Q · filed 2025-05-09 | -$20.54M derived: sum of 2 quarters · filed 2025-05-09 | -$38.91M derived: sum of 3 quarters · filed 2025-05-09 | -$60.97M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | -$11.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$29.75M derived: sum of 2 quarters · filed 2025-03-31 | -$51.80M derived: sum of 3 quarters · filed 2025-08-08 | -$72.49M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$18.37M 10-Q · filed 2024-11-12 | -$40.42M derived: sum of 2 quarters · filed 2025-08-08 | -$61.12M 10-Q · filed 2024-11-12 | -$78.97M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | -$22.06M 10-Q · filed 2025-08-08 | -$42.75M 10-Q · filed 2025-08-08 | -$60.60M derived: sum of 3 quarters · filed 2025-08-08 | -$79.53M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$20.69M 10-Q · filed 2025-05-09 | -$38.55M derived: sum of 2 quarters · filed 2025-05-09 | -$57.48M derived: sum of 3 quarters · filed 2025-05-09 | -$79.33M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$17.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$36.79M derived: sum of 2 quarters · filed 2025-03-31 | -$58.64M derived: sum of 3 quarters · filed 2025-03-31 | -$59.03M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$18.93M 10-Q · filed 2024-11-12 | -$40.78M derived: sum of 2 quarters · filed 2024-11-12 | -$41.18M 10-Q · filed 2024-11-12 | -$55.30M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$21.85M 10-Q · filed 2024-08-14 | -$22.25M 10-Q · filed 2024-08-14 | -$36.37M derived: sum of 3 quarters · filed 2024-08-14 | -$52.64M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$394.00K 10-Q · filed 2024-05-13 | -$14.51M derived: sum of 2 quarters · filed 2024-05-13 | -$30.79M derived: sum of 3 quarters · filed 2024-05-13 | -$19.34M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$14.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$30.39M derived: sum of 2 quarters · filed 2024-03-22 | -$18.95M derived: sum of 3 quarters · filed 2024-03-22 | -$31.63M 10-K · filed 2024-03-22 |
| 2022-09-30 | -$16.27M 10-Q · filed 2023-11-13 | -$4.83M derived: sum of 2 quarters · filed 2023-11-13 | -$17.51M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $11.45M 10-Q · filed 2023-09-01 | -$1.24M 10-Q · filed 2023-09-01 |